SetPoint Medical
Transform the Treatment of Rheumatoid Arthritis
- Headquarters
- Valencia, California
- Employees
- 51–200
- Founded
- 2007
- Business Model
- B2B
- Website
- setpointmedical.com
- Total Funding
- $245.0M
- Last Round
- $25.0M Series CAug 2025
About
SetPoint Medical developed the SetPoint System, the first FDA-approved implantable device for treating rheumatoid arthritis through neuroimmune modulation — delivering daily one-minute electrical stimulation to the vagus nerve to activate the body's natural anti-inflammatory pathways. The miniaturized, rechargeable neurostimulator is clinically proven to reduce tender and swollen joint counts by an average of 60% over 12 months. The company is also studying the platform for multiple sclerosis and other autoimmune conditions.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account